Download presentation
Презентация загружается. Пожалуйста, подождите
PublishChastity McCoy Modified over 10 years ago
1
PROJECT NOTIFY Sharing vigilance experience and knowledge globally - the NOTIFY Project (WHO)
2
Pre-Bologna – The Notify Google Site Oct 2010 – Feb 2011 Bologna Meeting (Feb 2011) Post Bologna BIG V&S B ologna I nitiative for G lobal V igilance and S urveillance
3
PROJECT NOT I F Y: The Google Site 10 global working groups led by international experts Co-ordinated by D Michael Strong
4
Definitions – EU and NOTIFY EU : ‘Serious Adverse Reaction (SAR)’ means an unintended response, including a communicable disease, in the donor or in the recipient associated with the procurement or human application of tissues and cells that is fatal, life-threatening, disabling, incapacitating or which results in, or prolongs, hospitalisation or morbidity (NOTIFY: An adverse response that HAS occurred, including a communicable disease, in a recipient or in a living donor) EU: ‘Serious Adverse Event (SAE)’ means any untoward occurrence associated with the procurement, testing, processing, storage and distribution of tissues and cells that might lead to the transmission of a communicable disease, to death or life-threatening, disabling or incapacitating conditions for patients or which might result in, or prolong, hospitalisation or morbidity (NOTIFY: An adverse occurrence that MIGHT lead to harm in a recipient or a living donor)
5
The Bologna Meeting Participants 116 attendees Regulators, government agencies, professional societies, international organisations, scientific and clinical experts in organ, tissue and cell transplantation and in assisted reproduction. 36 countries (Bulgaria, Italy, USA, Switzerland, Spain, France, Germany, Netherlands, Japan, India, Argentina, Portugal, Ireland, Denmark, Czech Republic, Lithuania, Slovenia, Australia, Brazil, Norway, Slovakia, Luxembourg, Thailand, Canada, Poland, Belgium, Singapore, Austria, Iran, South Africa, Russia, Croatia, Cyprus, Malta, Romania, Nigeria)
6
Working Groups 1-5 SubstanceLeaders OrgansPaolo Grossi (Italy) Matthew Kuehnert (CDC, USA) Francis Delmonico (The Transplantation Society) CorneasNaoshi Shinosaki (Japan) Paul Dubord (Canada) Marion Macsie (EEBA, USA) Other TissuesTed Eastlund (USA) Byoung-Suck Kim (Korea) Maurice Hinsenkamp (SICOT, Belgium) HPCLaura St Martin (FDA, USA) Dietger Niederwieser (WBMT, Germany) Kathy Loper (AABB) Gametes and Embryos Luca Gianaroli (ESHRE, Italy) Anne Cathrine Bollerup (Denmark) Mauro Costa (Italy) Groups 1-5 gathered documented cases of adverse reactions and events associated with organ, tissue or cell application in humans (with references), identifying the triggers that alerted clinicians and the procedures followed to clarify imputability
7
An example of a worksheet.... (HPCs) Over 1,700 references in total – Endnote Library
8
The Development of V&S Didactic Guidance Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Group 10 Master Sheet Genetic and Donor
9
The Development of V&S Didactic Guidance Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Group 10 Master Sheet Genetic and Donor
10
Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Group 10 Master Sheet Genetic and Donor The Development of V&S Didactic Guidance
11
Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Group 10 Master Sheet Genetic and Donor The Development of V&S Didactic Guidance
12
Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Group 10 Master Sheet Genetic and Donor The Development of V&S Didactic Guidance
13
Working Groups 6-10 SubstanceLeaders InfectionMike Ison (USA) Richard Tedder (UK) Francesco Procaccio (Italy) MalignancyRafael Matesanz (Spain) Antonietta Derrico Griggioni (Italy) Jeremy Chapman (Australia) Genetic and Donor Carolina Stylianou (Cyprus) Denis Confer (WBMT, NMDP, USA) Emanuele Cozzi (Italy) Product Property Diego Ponzin (Italy) Scott Brubaker (AATB, USA) Axel Rahmel (Eurotransplant, Efretos Project) Clinical Practice Lorenza Ridolfi (Italy) Renee de Vries (IHN) Paula Nolan (UK) Groups 6-10 regrouped the cases collected by groups 1-5 by type of reaction/event and developed guidance for clinicians for early detection and treatment and for establishing cause
14
An example of a master worksheet...
15
The Development of Notify V&S Guidance Group 1 List Reactions and Events in Organs Group 2 Lists Reactions and Events for Tissues (non ocular ) Group 3 Lists Reactions and Events for HSC Group 4 Lists Reactions and Events for Ocular Tissues Group 5 Lists Reactions and Events for Gametes and Embryos Group 6 Master Sheet Infections Group 7 Master Sheet Malignancy Group 8 Master Sheet Characteristics and Handling Group 9 Master Sheet Clinical Practice Errors Group 10 Master Sheet Genetic and Donor
17
www.notifylibrary.org
19
Ove 1800 references describing adverse outcomes in transplantation and assisted reproduction
20
A sample of the bibiography
21
Search by substance type : all organs, a specific organ, all tissues, a specific tissue etc. or by incident type : all reactions, reactions involving infection, reactions involving malignancy etc. or using key words or phrases: Search Result : Substance (e.g. Kidney) Reaction/ Event type e.g. WNV transmission LatencyUsual Alerting Signals Usual method of confirmation List of references (scientific literature or vigilance reports) with internet links where possible Analysis provided by international expert groups
24
.pdf for printing/saving of a search result with one record per page
25
Clicking on a single reference
26
Other Notify Outputs A WHO Booklet on Vigilance and Surveillance in draft A global network of vigilance experts discussing terminology, reviewing cases and developing guidance
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.